Oculus Innovative Sciences and Sinopharm Announce Introduction of Dermacyn(TM) to Hospitals in China Sep 11, 2008
Oculus Innovative Sciences to Present at the Merriman Curhan Ford 5th Annual Investor Summit on September 15 Sep 10, 2008
Oculus Innovative Sciences Reduces Planned Expenses While Accelerating Global Commercialization Sep 9, 2008
Oculus Innovative Sciences Holds Successful End-of-Phase II Meeting with FDA for Microcyn(R) Technology Sep 4, 2008
Oculus Innovative Sciences' CEO and Founder Named One of Pharmaceutical Executive's 2008 "Emerging Pharma Leaders" Jul 16, 2008
Oculus Innovative Sciences Announces Positive Results from Abstract Evaluating the Use of Microcyn(R) Technology in Treatment of Atopic Dermatitis Jul 1, 2008
Oculus Innovative Sciences Announces Agreement With Bayer (Sichuan) Animal Health Co. Ltd. for Development of Microcyn(R) Technology Use in Chinese Animal Market Jun 23, 2008
Oculus Innovative Sciences Announces Agreement with Bayer Australia Limited for Development of Microcyn(R) Technology Use in Australian Animal Market Jun 19, 2008
Oculus Innovative Sciences Announces Development of Microcyn(R)-Based Hydrogel Formulation Jun 17, 2008
